Dynamic Biosensors
Founded 2013 · 57 employees on LinkedIn · 2 known investors
Find your way into Dynamic Biosensors
Sign up to see every warm intro you have to Dynamic Biosensors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dynamic Biosensors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dynamic Biosensors develops the heliX biosensor instruments and switchSENSE and single-cell Interaction Cytometry (scIC) technologies for characterizing molecule-molecule and molecule-cell interactions and binding kinetics. Its instruments serve researchers in drug discovery and life sciences studying biophysical molecular interactions; the company was acquired by Bruker in 2024.
Investors · 2
Frequently asked questions
- What does Dynamic Biosensors do?
- Dynamic Biosensors develops the heliX biosensor instruments and switchSENSE and single-cell Interaction Cytometry (scIC) technologies for characterizing molecule-molecule and molecule-cell interactions and binding kinetics. Its instruments serve researchers in drug discovery and life sciences studying biophysical molecular interactions; the company was acquired by Bruker in 2024.
- Who are Dynamic Biosensors's investors?
- Dynamic Biosensors's investors include Bayern Kapital, UVC Partners.


